NOS2 and Cognitive impairment: Regarding outcomes after carotid revascularization procedures, a variation in the inducible nitric oxide synthase polymorphism offers a defense against moderate to severe cognitive impairment (that appears in 9% to 23% of patients) one month after CEA.